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ABstRAct
Polymorphous Low-Grade Adenocarcinoma is a rare, malignant salivary gland tumor, which is found almost exclusively 
in minor salivary glands.  It is more frequent in the age range from 30 to 70, with a clear female predilection in a 2:1 
ratio.  It is usually located in the hard or soft palate, although it may be found in the rest of the oral cavity too.  It is rare 
in major salivary glands.  In general it has good prognosis, with recurrence rates in the range of 17% - 24%.  Although 
rare, metastasis to regional lymph nodes may occur in 9% of the cases. 
This report describes the case of a patient that consulted at the Military Odontological Center (Central Odontológica 
del Ejército) due to an esthetic alteration of her dental prosthesis, which had been  made 8 years before.  The patient 
was sent to the Maxillofacial Surgery Service, where the intraoral examination showed a big mass compromising the 
hard palate and the alveolar ridge.  During examination, a dent in her prosthesis was found to correspond to the tumor 
mass; it was therefore concluded that the tumor had at least an eight-year-old evolution.  An incisional biopsy was car-
ried out, and once the polymorphous low-grade adenocarcinoma diagnosis had been stated, the patient was sent to the 
Head and Neck Surgery Service of the Military Hospital, where the lesion was treated by wide surgical excision followed 
by radiation therapy. 
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IntRoductIon
Minor salivary gland malignant neoplasms account for 
2 - 4% of head and neck malignant neoplasms, 10% of 
all oral cavity malignant neoplasms and 15 - 23% of all 
salivary gland malignant neoplasms (1).  Among the latter, 
the polymorphous low-grade adenocarcinoma (PLGA) is 
found, which was first described in 1983 simultaneously by 
Batsakis et al and Freedman and Lumerman who named it 
as Terminal Duct Carcinoma and Lobular Carcinoma (2). 
Before being described as an entirely different entity, this tu-
mor was diagnosed as Pleomorphic Adenoma or Unspecific 
Carcinoma or even sometimes as Adenoid Cystic Carcinoma 
(3).  It is a malignant neoplasm of salivary glands, more 
frequently detected in minor salivary glands (4).  It is a rare 
pathology that affects people in the age range from 30 to 70, 
with a female predilection in a 2:1 ratio (5).  Polymorphous 
low grade adenocarcinoma is found almost exclusively in 
minor salivary glands (3), and is rare in extraoral locations, 
including major salivary glands.  Sixty percent of the cases 
occur on the hard or soft palate, followed by 13% of the cases 
occuring in the buccal mucosa, 10% in the upper lip, 6% in 
the retromolar area, and 9% in the rest of the oral cavity 
(5).  The lesion is  normally described as a painless, slow-
growing mass, covered by non-ulcerated mucosa.   In some 
cases it may be adhered to deep planes and it can reach sizes 
between 1 and 4 cm (3, 5).  Diagnosis is late and can take 
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weeks or even years because of its slow growth. This lesion 
can erode or infiltrate bone tissue (3).  Histology shows a 
non-encapsulated lesion with infiltrative margins.  It is na-
med as polymorphous due to its different growth patterns: 
tubular, solid, papillary, microcystic, cribiform, fascicular, 
and cords.  It can infiltrate bone tissue and even present 
perivascular and perineural invasion.  The best treatment is 
surgical excision including the subjacent bone, if  necessary 
(3,5). This surgery is frequently followed by radiotherapy. 
The prognosis is good and recurrence rate ranges between 
17% and 24%.  Metastasis is unusual (9%) but in case it 
occurs, it mainly affects regional lymph nodes (6).
cAse RePoRt
A 65 year-old female patient consults due to an esthetic al-
teration of her removable prosthesis.  The problem was that 
it was progressively exposing the teeth of one side (Figure 
1).  The patient was immediately sent to the maxillofacial 
surgery service where the intraoral examination showed a 
big mass located in the hard palate and part of the right 
alveolar ridge, which caused an evident maladjustment of 
the prosthesis.  The patient said she had noticed this mass 
one year ago and that, during this period, it had showed a 
very slow growth.  Clinically, the lesion was a big soft mass 
of 5 cm diameter, with gummy consistency, painless, not 
adhered to deep planes and covered with normal mucosa 
(Figure 2). During the exam, a dent corresponding to the 
lesion was observed in the patient’s prosthesis.  The pros-
thesis had been made 8 years ago, which determined that 
the lesion was there before the prosthesis was made (Figure 
3), and that it had had a very slow growth, thus producing 
an actual maladjustment in the last year.  An orthopanto-
mography revealed a more radiopaque lesion located in the 
palatal region, but did not indicate if  it was infiltrating bone 
tissue or not.  Watters radiography revealed no compromise 
of ipsilateral maxillary sinus.  Incisional biopsy was planned 
and sent to hystopathological analysis which confirmed 
polymorphous low grade adenocarcinoma diagnosis (Figure 
4).  Because of its malignant condition, the patient was 
sent to the Head a Neck Surgery Service of the Military 
Hospital where surgical excision with security margins was 
performed.  The lesion reached the excision margins and it 
presented positive bone and perineural infiltration so the 
patient was subsequently submitted to radiotherapy.
dIscussIon
Polymorphous low grade adenocarcinoma is a rare lesion. 
In a research study carried out by González Lagunas (1), 
a sample of 59 malignant salivary gland tumors was as-
sessed, and no PLGA was found.  This lesion is located 
almost exclusively in minor salivary glands within the oral 
cavity, mostly hard palate, being its extraoral presentation 
extremely rare.  Nasal fossa and nasopharynx locations 
have been described in less that 0.5 – 1% of the cases (7). 
There is a clear female predilection, particularly affecting 
women  in their fourties and fifties.  This characteristic is 
also found in other salivary gland neoplasms (5,8) that 
Fig. 1. Clinical image that shows the right side 
descent of the prothesis.
Fig. 2. Clinical image that shows the palatal and 
alveolar bone mass.
Fig. 3. Clinical image that shows the prothesis`s 
lesion impression.
Fig. 4. Histological image that shows ductal or tu-
bular like structures with a central lumina formed 
by one layer of cubic cells.
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may appear as multiple benign or malign salivary gland 
tumors, and this is the reason why it was wrongly diagnosed 
during a long time.  Differential diagnosis is important in 
the case of benign tumors such as pleomorphic adenoma. 
This tumor often shows a very similar clinic behaviour, 
which sometimes generates a dilemma in the histological 
analysis.  This especially occurs within lesions with a large 
number of cells and few matrix, with no fibrous capsule, 
which is common in minor salivary gland tumors but not 
in major salivary gland tumors (2). This is the reason why 
immunohystochemistry is an important tool when dealing 
with salivary gland neoplasms (9).  Pleomorphic adenoma 
shows immunoreactivity for GFAP (glial fibrillary acid 
protein) which is normally present in nervous system cells, 
specifically in glial cells.  However, the presence of this an-
tibody has also been described in other tumors of non-glial 
origin.  PLGA has minimum or none reactivity to GFAP 
which is a difference with pleomorphic adenoma (2).  Other 
immunohystochemical studies have shown that polymor-
phous low grade adenocarcinoma expresses big amounts 
of vimentin, which is absent in canalicular adenoma. These 
two tumors share similar hystological characteristics, being 
vimentin a useful marker for the differential diagnosis of 
both lesions (9). 
Among the malignant lesions we may mention the ade-
noid cystic carcinoma, that despite of being a malignant 
neoplasm as PLGA, shows a different clinical behaviour. 
Adenoid cystic carcinoma is much more aggressive, has a 
faster growth and a high metastasis rate (10).
This case evidences the low grade of malignancy and slow 
growth of PLGA which is demonstrated with the fact that 
the tumor was there before the prosthesis was made 8 years 
ago.  During all this time, no symptoms were noticed by the 
patient except for the presence of a mass in her palate.  It 
is important to underline that physical examination before 
any dental treatment must be accurate, and all perceptible 
swellings must be evaluated by means of appropriate radio-
graphs or other complementary exams.
Polymorphous low grade adenocarcinoma described in this 
report corresponds to the experience described in other 
countries, with high incidence in palate and slow growth. 
Hystological findings are also similar to those described 
above: lobular growth, cord-like infiltration, and pale, 
ovoid nuclei.
concLusIon
Polymorphous low grade adenocarcinoma is a rare malig-
nant neoplasm, with a clinical behavior similar to that of 
a benign neoplasm, with low symptomatology, which may 
determine a late diagnosis like it was in the case presented 
in this report.
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